TP53 and atherosclerosis: In our study, using in vitro and in vivo models of atherosclerosis-induced VSMC senescence, we provide evidence that paeonol treatment produces a significant inhibitory effect on VSMCs senescence and telomere damage through the SIRT1/P53/TRF2 signaling pathway.